Across the city, firm-to-firm meetings take place informally, and one wonders what deals are being hammered out in hotel lobbies, in coffee shops, on Union Square, and on every floor of Macy’s—anywhere there’s a corner to sit and talk in semi-privacy. In the evening, socials pop up across the city, hosted by law firms and investment houses, where the deal-making and networking continues, fueled by cocktails.

Amitai Shenhav is one of eight psychological scientists nationwide to receive the 2020 Janet Taylor Spence Award from the Association for Psychological Science (APS).

Alzheimer's is the sixth leading cause of death in the United States, and 5.8 million Americans are living with this disease. Salloway, who is affiliated with Brown's Robert J. and Nancy D. Carney Institute for Brain Science, leads the Rhode Island studies of the first drug to prevent Alzheimer’s.

The last 12 months saw a whirlwind of brain science-related news and the Carney Institute was no exception. From the unveiling of Carney's new innovation hub to breakthroughs in the lab, here in chronological order are Carney's top stories of 2019.

The Corporation of Brown University approved the appointment of five faculty affiliated with the Carney Institute to endowed professorships in the calendar year of 2019. Below is a list of those faculty members and information about their research.

Since May, I have been conducting a comprehensive innovation study with John Davenport, managing director of the Carney Institute, and Brian Demers, director of business development at Brown University’s Office of Industry Engagement and Commercial Venturing. We found that Carney has a rich portfolio of ideas that could be moved from the bench to the clinic or marketplace.

2019 has been spectacular for the Robert J. and Nancy D. Carney Institute for Brain Science because of contributions from members of our community.

In this special installment of Podcasts360, Andrew Blum, MD, PhD, and Wael Asaad, MD, PhD, discuss their case series on responsive neurostimulation, why they chose responsive neurostimulation for each patient, and how the technology has evolved over the years.

Recent hires, game-changing grants, and collaboration are helping to position Brown’s Carney Institute for Brain Science as a global leader in Alzheimer’s research and treatment.

Over the past few years the institute has increased funding into its research on how the human brain works, and it has expanded the results of that research by an impressive margin. The center brings together more than 180 world-class faculty members and their research groups across 23 Brown University departments, according to Sara Feijo, communications and outreach manager.

Nine scientists affiliated with the Robert J. and Nancy D. Carney Institute for Brain Science have received innovation awards from the institute to take risks and test bold ideas.

The Institute welcomes submissions from students in all disciplines. Submissions are due by 5 p.m. February 22, 2019. Selected artists will be contacted by March 8, 2019. Size of commission will be proportional to the scope of the proposed project.

Diane joined the faculty at Brown in 1990, following a BSc and PhD in Pharmacology at University College London, and a postdoctoral fellow at Yale University and Stanford University Schools of Medicine. Diane is an expert in a class of proteins – Calcium Ion Channels – that regulate most of the essential function of cells in muscle, brain, and secretory glands. Abnormal functioning of these proteins underlie several neurological and psychiatric diseases and they are important targets of drugs that lower blood pressure and that alleviate intractable, chronic pain. Her research is supported by grants from the NIH, NSF, ALS Finding a Cure Foundation, and Keck Foundation.

Biotech firm Biogen could double its market cap if it receives approval from the Food and Drug Administration (FDA) for its experimental Alzheimer’s drug, aducanumab, said CNBC’s "Mad Money" host Jim Cramer Wednesday.

Last week, we spent five days in Chicago, Ill., exploring emerging science and new tools and technologies with approximately 30,000 neuroscientists at the Society for Neuroscience (SfN) Annual Meeting.

Neuroscientist Jason Ritt is on a mission to assess the depth of brain science potential at Brown University, and to find ways to facilitate the sharing of ideas and methods across laboratories.

The successful applicant will have an outstanding record of research and teaching, which contributes to the mission of the home department and the Carney Institute. We are particularly interested in scholars who demonstrate commitment to promoting diversity and inclusion in the brain sciences.

Perception and action interact constantly, and a new study by Carney Institute researchers has found that perceptual-discrimination performance improves as actions became more fluent.

The Root 100 is our annual list of the most influential African Americans, ages 25 to 45. It’s our way of honoring the innovators, the leaders, the public figures and game changers whose work from the past year is breaking down barriers and paving the way for the next generation. This year’s list of honorees is a reminder of the beauty and brilliance of blackness, at a time when the political and cultural landscape has grown even more hostile to the idea of black achievement.

Should you sell your stock or buy more of it? What is the best meal to order at your favorite restaurant? Such decisions are often made by considering expected outcomes — but where do those expectations come from?